CClinicalTrials.gg
Not yet recruitingNCT07469631INNERWORLDUpdated Mar 13, 2026

Brain Networks Involved in Inner World Control

An interventional study of Neuropsychological evaluation, questionnaires, and training on the tasks that will be performed in the MRI. and MRI visits in Neurosciences, sponsored by Hospices Civils de Lyon. Not yet recruiting at 2 sites in France. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Inner speech (the "little voice" in our heads) plays a central role in our ability to perform complex cognitive tasks such as problem solving, reading, writing, thinking, and self awareness. It is estimated that at least a quarter of our lives is accompanied by inner speech, whether deliberate (mentally making a list) or more spontaneous (mind wandering). Although central to human life, its neural bases remain poorly understood. It has been recently discovered a single region in the human prefrontal cortex absent in nonhuman primates, the prefrontal operculum (PFO), which shows a pattern of functional connectivity with the rest of the brain that could give it a role in controlling inner speech. The aim of this research is to understand how the brain generates and controls inner speech using functional magnetic resonance imaging (fMRI). Dysfunctions of inner speech, especially when spontaneous and wandering, can lead to severe mental disorders (anxiety disorders, depression, verbal auditory hallucinations). It is therefore crucial to identify the role of the PFO and the networks that involve it, particularly the precuneus, in controlling inner speech across its different manifestations. The first hypothesis is that the PFO and the networks that include it play a key role in the cognitive control of inner speech in participants who experience inner speech. The second hypothesis is that the PFO is hyperactive in participants who lack inner speech (so called aphantasics), preventing the production of inner speech. To test these hypotheses, participants will complete a battery of well established questionnaires to determine whether they can produce inner speech (control participants with typical inner speech) or not (aphantasic participants). These participants will take part in an fMRI study contrasting tasks that recruit inner speech that do or do not require cognitive control. The third hypothesis is that the extent of inner speech depends on the capacity for self representation, and thus on the interaction between the PFO and the precuneus. The investigator hypothesize a positive correlation between inner speech ability and self representation capacity, associated with stronger functional connectivity between the PFO and the precuneus. The investigator predict reduced self representation in aphantasic participants. To test this, participants will complete a battery of well established questionnaires. The investigator will compute correlations between 1) behavioral performance on inner speech tasks and questionnaire scores, and 2) the network measures identified in fMRI (task activation and connectivity) and questionnaire scores.

02

Conditions studied

  • Neurosciences

Keywords

  • Prefrontal operculum
  • precuneus
  • inner language
  • self
  • imaging
03

In context

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Registered with the national Social Security system.
  • Right handed.
  • Native French speakers.
  • Visual acuity sufficient to read stimuli (contact lenses permitted).
  • Willing to follow MRI instructions and recommendations.
  • Able to provide written informed consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • History of known neurological or psychiatric disorder.

    • Respiratory pathologies (in particular persistent asthma) or cardiovascular diseases.
    • Speech or language disorders (aphasia, dysphasia, dysarthria, stuttering, etc.).
    • Hearing impairments.
    • Memory disorders.
    • Cognitive impairments limiting understanding of instructions.
    • Recent use of psychotropic medications. Major treatments not permitted in this research include psychotropic drugs that can alter perception, sensations, mood, consciousness, or behavior, for example:

      • Antipsychotics (valproic acid, amisulpride, aripiprazole, clozapine, cyamemazine, haloperidol, loxapine, olanzapine, risperidone).
      • Antidepressants (amitriptyline, citalopram, clomipramine, duloxetine, escitalopram, fluoxetine, mianserin, mirtazapine, nortriptyline, paroxetine, sertraline, venlafaxine).
      • Anxiolytics.
    • Pregnant or breastfeeding women. No pregnancy test will be performed at inclusion; pregnancy must be reported by self declaration.
    • Minors.
    • Persons deprived of liberty by judicial or administrative decision.
    • Persons admitted to a health or social institution for reasons other than research.
    • Adults under legal protection measures (guardianship, conservatorship).
    • Persons not affiliated with a social security scheme or with a similar scheme only.
    • Participants refusing to be informed in case of an incidental finding on MRI.
    • Contraindications to fMRI, including:

      • Pacemaker, neurosensory stimulator, or implantable defibrillator: risk of transient or permanent device damage or heating of metal parts. In patients with such devices, scanning should be performed only if absolutely necessary, with the patient's informed agreement after clear explanation of risks, and in the presence of a physician from the referring service.
      • Metallic prostheses: potential for significant artifacts depending on size and ferromagnetic properties; certain neurosurgical clips or cardiac valves may pose problems and require verification of the exact implanted model.
      • Ferromagnetic ocular or intracranial foreign bodies near nervous structures: risk of displacement and ocular or cerebral injury.
      • Cochlear implants: risk of demagnetization, electrode heating, and artifacts.
      • Neurosurgical shunt valves.
      • Claustrophobic participants.
      • Dental appliances.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Neurotypical subjects

    The study population will consist of healthy adult human participants, male and female, with inner speech, whose native language is French

    Behavioral: Neuropsychological evaluation, questionnaires, and training on the tasks that will be performed in the MRI. · Other: MRI visits

  • Experimental
    Aphantasic subjects

    The study population will consist of healthy adult human participants, male and female, without inner speech, whose native language is French

    Behavioral: Neuropsychological evaluation, questionnaires, and training on the tasks that will be performed in the MRI. · Other: MRI visits

Interventions

  • BehavioralNeuropsychological evaluation, questionnaires, and training on the tasks that will be performed in the MRI.

    The neuropsychological/questionnaires evaluation is a 3 hour visit during which participants will complete a battery of neuropsychological tests and respond to questionnaires assessing their capacity for inner speech and self representation. In a second 30 minute visit, they will be trained on the tasks (inner speech tasks and control tasks) that they will perform in the MRI.

  • OtherMRI visits

    There will be two 2 hour MRI visits. During the first visit, participants will perform the learned task conditions designed to test the control of inner speech; during the second visit, they will perform the control conditions and an anatomical MRI will be acquired, as well as a resting state fMRI scan to study functional connectivity and a DTI scan to study structural connectivity

06

What researchers measure

Primary outcomes

  1. To assess the role of the prefrontal operculum (PFO) (and the brain network to which it belongs)

    MRI measurement (without contrast injection) according to the conditions of inner speech used

    Time frame: at 60 days

Secondary outcomes

  1. To assess the relation between MRI and behavioral measures - behavioral performance

    MRI (task activation and functional connectivity) and diffusion tensor imaging DTI (structural connectivity) in correlation with behavioral performance on inner speech tasks. The unit of the behavioral performance is the percent correct

    Time frame: during 60 days

  2. To assess the relation between MRI and behavioral measures - inner speech

    MRI (task activation and functional connectivity) and diffusion tensor imaging DTI (structural connectivity) in correlation with scores on inner speech and self perception questionnaires specific to each participant (unit reflecting the participants' profile).

    Time frame: during 60 days

07

Study locations

2 sites
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07469631
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Mar 13, 2026
Start date
May 1, 2026 (estimated)
Primary completion
May 1, 2028 (estimated)
Completion
May 1, 2028 (estimated)
Last update
Mar 13, 2026

Study contacts

Fadila Hadj-Bouziane
Contact
fadila.hadj-bouziane@inserm.fr
04 72 91 34 04

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion